BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 21208540)

  • 1. [Expression of Kai1 and FasL in non-small cell lung cancer and its clinicopathological significance].
    Li Y; Wu D; Zheng H; Xin Y
    Zhongguo Fei Ai Za Zhi; 2005 Dec; 8(6):518-22. PubMed ID: 21208540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Expression of KAI1 gene in non-small cell lung cancer and its relationship with P53].
    Guo C; Pan T; Tang Y; Zhou Y; Zheng Z
    Zhongguo Fei Ai Za Zhi; 2005 Jun; 8(3):190-4. PubMed ID: 21190617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results.
    Zhao ZH; Wang SF; Yu L; Wang J; Chang H; Yan WL; Zhang J; Fu K
    Lung Cancer; 2008 Oct; 62(1):113-9. PubMed ID: 18550205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Expression and clinical significance of caspase-3,survivin and k-ras in non-small cell lung cancer.].
    Li C; Hu B; Wang X; Ji C; He Y
    Zhongguo Fei Ai Za Zhi; 2008 Feb; 11(1):90-6. PubMed ID: 20727274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Expression of KAI1 protein in tissue microarray and its biological significances in patients with lung cancer].
    Liu T; Wang X; Zhu C; Li Y; Sun C; Wang A
    Zhongguo Fei Ai Za Zhi; 2005 Apr; 8(2):116-9. PubMed ID: 21189178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Relationship of clusterin expression with Bax and p53 expression in non-small cell lung cancer].
    Niu L; Zang J; Cai L; Li C; Cao H
    Zhongguo Fei Ai Za Zhi; 2007 Aug; 10(4):284-7. PubMed ID: 21122294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Expression of LYVE-1 and Prox-1 in non-small cell lung cancer and the relationship with lymph node metastasis].
    Chang C; Wang P; Yang H; Li L; Zhang LB
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2011 Mar; 42(2):174-8. PubMed ID: 21500548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of KAI1 expression in the progression of colorectal cancer.
    Lombardi DP; Geradts J; Foley JF; Chiao C; Lamb PW; Barrett JC
    Cancer Res; 1999 Nov; 59(22):5724-31. PubMed ID: 10582691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. KAI1 metastasis suppressor protein is down-regulated during the progression of human endometrial cancer.
    Liu FS; Dong JT; Chen JT; Hsieh YT; Ho ES; Hung MJ; Lu CH; Chiou LC
    Clin Cancer Res; 2003 Apr; 9(4):1393-8. PubMed ID: 12684410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Expressions of survivin and caspase-3 in human non-small cell lung cancer and their relationship with cell apoptosis].
    Wang J; Chen L; Huang W; Li G; Meng K; Guan X; Wang C
    Zhongguo Fei Ai Za Zhi; 2005 Oct; 8(5):435-9. PubMed ID: 21205528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of STAT3 expression and its correlation with chemoresistance of non-small cell lung cancer cells.
    Yin Z; Zhang Y; Li Y; Lv T; Liu J; Wang X
    Acta Histochem; 2012 Feb; 114(2):151-8. PubMed ID: 21549414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of KAI1/CD82 gene expression with good prognosis in patients with non-small cell lung cancer.
    Adachi M; Taki T; Ieki Y; Huang CL; Higashiyama M; Miyake M
    Cancer Res; 1996 Apr; 56(8):1751-5. PubMed ID: 8620488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Different expressions of p53 gene family members and their clinical significance in human non-small cell lung cancer].
    Chen F; Chen H; Tao H; Zhang Y; Ye B; Liu M
    Zhongguo Fei Ai Za Zhi; 2004 Aug; 7(4):339-43. PubMed ID: 21241556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Detection of interleukin-8 on tissue array of non-small cell lung cancer and its clinicopathological significance].
    Xu C; Bian X; Wang Q; Zhang R; Chen C; Ye Q
    Zhongguo Fei Ai Za Zhi; 2007 Oct; 10(5):386-90. PubMed ID: 21126406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of Fas and Fas ligand expressions in human esophageal cancer.
    Shibakita M; Tachibana M; Dhar DK; Kotoh T; Kinugasa S; Kubota H; Masunaga R; Nagasue N
    Clin Cancer Res; 1999 Sep; 5(9):2464-9. PubMed ID: 10499620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A polymorphic -844T/C in FasL promoter predicts survival and relapse in non-small cell lung cancer.
    Sung WW; Wang YC; Cheng YW; Lee MC; Yeh KT; Wang L; Wang J; Chen CY; Lee H
    Clin Cancer Res; 2011 Sep; 17(18):5991-9. PubMed ID: 21807637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered expression of survivin, Fas and FasL contributed to cervical cancer development and metastasis.
    Wu SF; Zhang JW; Qian WY; Yang YB; Liu Y; Dong Y; Zhang ZB; Zhu YP; Feng YJ
    Eur Rev Med Pharmacol Sci; 2012 Dec; 16(15):2044-50. PubMed ID: 23280017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and clinical significance of matrix metalloproteinase (MMP)-26 protein in non-small cell lung cancer.
    Li L; Mei TH; Zhou XD; Zhang XG
    Ai Zheng; 2009 Jan; 28(1):60-3. PubMed ID: 19448419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expression of survivin gene and its significance in the carcinogenesis and development of non-small cell lung cancer].
    Tao L; Yao F; Li H; Yu F; Wang M; Liu M
    Zhongguo Fei Ai Za Zhi; 2003 Aug; 6(4):275-7. PubMed ID: 21272481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Expressions of Nm23, E-cadherin, and beta-catenin in non-small cell lung cancer and their correlations with metastasis and prognosis].
    Tang XJ; Zhou QH; Zhang SF; Liu LX
    Ai Zheng; 2005 May; 24(5):616-21. PubMed ID: 15890109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.